Showing results (301-310 of 335) with videos related to
Sort By:
Pageof 34
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2010
Alternating systemic and hepatic artery infusion therapy for resected liver metastases from colorectal cancer: a North Central Cancer Treatment Group (NCCTG)/ National Surgical Adjuvant Breast and Bowel Project (NSABP) phase II intergroup trial, N9945/CI-66Steven R Alberts, Mark S Roh, Michelle R Mahoney, et al.Cancer Chemotherapy and Pharmacology|February 13, 2015
Alliance A091103 a phase II study of the angiopoietin 1 and 2 peptibody trebananib for the treatment of angiosarcomaSandra P D' Angelo, Michelle R Mahoney, Brian A Van Tine, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium studySam J Lubner, Michelle R Mahoney, Jill L Kolesar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2002
Efficacy and quality-of-life data are related in a phase II trial of oral chemotherapy in previously untreated patients with metastatic colorectal carcinomaTimothy J Hobday, John W Kugler, Michelle R Mahoney, et al.Frontiers in Aging Neuroscience|April 17, 2023
Visual-somatosensory integration (VSI) as a novel marker of Alzheimer's disease: A comprehensive overview of the VSI studyJeannette R Mahoney, Helena M Blumen, Pierfilippo De Sanctis, et al.Molecular Psychiatry|July 24, 2019
Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer's diseaseEmily R Mahoney, Logan Dumitrescu, Annah M Moore, et al.Cancer|February 22, 2002
Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factorJohn H Edmonson, Ivy A Petersen, Thomas C Shives, et al.Cancer|August 10, 1999
Clinicopathologic study of 85 similarly treated patients with anaplastic astrocytic tumors. An analysis of DNA content (ploidy), cellular proliferation, and p53 expressionA Perry, R B Jenkins, J R O'Fallon, et al.Neurobiology of Aging|July 27, 2022
RNASE6 is a novel modifier of APOE-ε4 effects on cognitionMabel Seto, Rebecca L Weiner, Logan Dumitrescu, et al.JCI Insight|June 26, 2019
RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancerOghenekevwe M Gbenedio, Caroline Bonnans, Delphine Grun, et al.Pageof 34